Τρίτη 16 Ιανουαρίου 2018

Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.

Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.

Cancer Biol Ther. 2018 Jan 15;:0

Authors: Kim YJ, Sung M, Oh E, Van Vrancken M, Song JY, Jung K, Choi YL

Abstract
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by poor patient prognosis and for which no targeted therapies are currently available. TNBC can be further categorized as either basal-like (BLBC) or quintuple-negative breast cancer (QNBC). In the present study, we aimed to identify novel molecular therapeutic targets for TNBC by analyzing the mRNA expression of TNBC-related genes in publicly available microarray data sets. We found that Engrailed 1 (EN1) was significantly overexpressed in TNBC. Using breast cancer cell lines, we found that EN1 was more highly expressed in TNBC than in other breast cancer subtypes. EN1 expression was analyzed in 199 TNBC paraffin-embedded tissue samples by immunohistochemistry. EN1 protein expression was positively associated with reduced overall survival (OS) rate in patients with QNBC, but not those with BLBC. The importance of EN1 expression in QNBC cell viability and tumorigenicity was evaluated using the QNBC cell lines, HCC38 and HCC1395. Based on our data, EN1 may promote the proliferation, migration, and multinucleation of QNBC cells, likely via the transcriptional activation of HDAC8, UTP11L, and ZIC3. We also demonstrated that actinomycin D effectively inhibits EN1 activity in QNBC cells. The results of the present study suggest that EN1 activity is highly clinically relevant to the survival prognosis of patients with QNBC and EN1 is a promising potential therapeutic target for future QNBC treatment.

PMID: 29333926 [PubMed - as supplied by publisher]



from Cancer via ola Kala on Inoreader http://ift.tt/2D8EQrZ
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου